Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Change in Receivables (2016 - 2024)

Historic Change in Receivables for Prothena Corp Public (PRTA) over the last 12 years, with Q1 2024 value amounting to -$5.2 million.

  • Prothena Corp Public's Change in Receivables changed N/A to -$5.2 million in Q1 2024 from the same period last year, while for Dec 2024 it was -$5.2 million, marking a year-over-year decrease of 20000.0%. This contributed to the annual value of -$5.2 million for FY2024, which is 20000.0% down from last year.
  • Latest data reveals that Prothena Corp Public reported Change in Receivables of -$5.2 million as of Q1 2024.
  • In the past 5 years, Prothena Corp Public's Change in Receivables registered a high of $4.6 million during Q3 2023, and its lowest value of -$5.2 million during Q1 2024.
  • For the 4-year period, Prothena Corp Public's Change in Receivables averaged around -$6181.8, with its median value being -$7000.0 (2020).
  • Examining YoY changes over the last 5 years, Prothena Corp Public's Change in Receivables showed a top increase of 202000.0% in 2020 and a maximum decrease of 158571.43% in 2020.
  • Over the past 4 years, Prothena Corp Public's Change in Receivables (Quarter) stood at -$7000.0 in 2020, then tumbled by 1028.57% to -$79000.0 in 2021, then soared by 5967.09% to $4.6 million in 2023, then crashed by 211.31% to -$5.2 million in 2024.
  • Its Change in Receivables stands at -$5.2 million for Q1 2024, versus $4.6 million for Q3 2023 and $524000.0 for Q2 2023.